| 365.08 0.43 (0.12%) | 11-11 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 427.68  |
1-year : | 499.53 |
| Resists | First : | 366.17 |
Second : | 427.68 |
| Pivot price | 344.4 |
|||
| Supports | First : | 328.76 |
Second : | 305.64 |
| MAs | MA(5) : | 360.93 |
MA(20) : | 339.29 |
| MA(100) : | 305.08 |
MA(250) : | 279.06 |
|
| MACD | MACD : | 13.1 |
Signal : | 10.9 |
| %K %D | K(14,3) : | 95.1 |
D(3) : | 93.2 |
| RSI | RSI(14): 82.7 |
|||
| 52-week | High : | 366.17 | Low : | 223.91 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ COR ] has closed below upper band by 8.8%. Bollinger Bands are 136.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 16 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 366.39 - 367.47 | 367.47 - 368.69 |
| Low: | 359.09 - 360.44 | 360.44 - 361.94 |
| Close: | 362.72 - 364.74 | 364.74 - 367 |
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Tue, 11 Nov 2025
COR: JP Morgan Raises Cencora's Price Target to $417 | COR Stock News - GuruFocus
Tue, 11 Nov 2025
Wells Fargo Raises Cencora (COR) Price Target to $405 | COR Stoc - GuruFocus
Tue, 11 Nov 2025
Cencora Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
Sat, 08 Nov 2025
COR: UBS Raises Cencora Price Target to $415, Reiterates Buy Rat - GuruFocus
Fri, 07 Nov 2025
Can Cencora’s (COR) Dividend Hike Offset Investor Concerns Over Goodwill Impairment Charges? - simplywall.st
Fri, 07 Nov 2025
Cencora: Earnings Visibility Driving Re-Rating Potential (NYSE:COR) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 194 (M) |
| Shares Float | 186 (M) |
| Held by Insiders | 4.1 (%) |
| Held by Institutions | 93.8 (%) |
| Shares Short | 4,790 (K) |
| Shares Short P.Month | 6,700 (K) |
| EPS | 9.75 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.22 |
| Profit Margin | 0.6 % |
| Operating Margin | 1.2 % |
| Return on Assets (ttm) | 3 % |
| Return on Equity (ttm) | 116.7 % |
| Qtrly Rev. Growth | 8.6 % |
| Gross Profit (p.s.) | 55.54 |
| Sales Per Share | 1633.22 |
| EBITDA (p.s.) | 23.57 |
| Qtrly Earnings Growth | 45.5 % |
| Operating Cash Flow | 1,740 (M) |
| Levered Free Cash Flow | 1,290 (M) |
| PE Ratio | 37.44 |
| PEG Ratio | 0 |
| Price to Book value | 35.72 |
| Price to Sales | 0.22 |
| Price to Cash Flow | 40.67 |
| Dividend | 0.55 |
| Forward Dividend | 0 |
| Dividend Yield | 0.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|